The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
基本信息
- 批准号:8652710
- 负责人:
- 金额:$ 32.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-05 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdenocarcinomaAffinityAnteriorAntibioticsAntralBacteriaBindingBiochemicalBiological AssayCellsChemicalsChemoreceptorsChemotaxisConfocal MicroscopyCuesDataDiseaseDisease OutcomeDrug or chemical Tissue DistributionDuodenal UlcerEngineeringEnvironmentEpithelialEpithelial CellsEpitheliumGastric GlandsGastric Parietal CellsGastritisHabitatsHelicobacter InfectionsHelicobacter pyloriHumanImpairmentIndividualInfectionKnowledgeLeadLigandsMalignant NeoplasmsMeasuresMediatingMedicalMethodsMicrobial BiofilmsMovementMucous MembraneMusOrganPathogenesisPatternPerceptionPeriplasmic Binding ProteinsPopulationPropertyProteinsResearch PersonnelResolutionRoleSignal TransductionStomachStomach DiseasesStructureSurfaceSystemTestingTropismUlcerUreaVAI-2basecell motilitydensitydesignin vivo Modelinsightmonolayermutantnext generationnovelpathogenperiplasmpreventpublic health relevancequorum sensingreceptorresponsestructural biology
项目摘要
PROJECT SUMMARY
Helicobacter pylori is a human gastric pathogen that colonizes half the world's population and causes a wide
range of diseases including gastritis, ulcers, and cancer. The distribution of the bacteria in the stomach is
correlated with disease outcomes, but the factors that determine this distribution are unknown. We hypothesize
that chemotaxis, the ability of bacteria to sense and orient their movement in response to chemical gradients in
their environment, is a key determinant of H. pylori distribution in the stomach. H. pylori is ideally suited for
testing the role of bacterial chemotaxis in tissue distribution, because it has a simple chemotaxis system with
only three core chemoreceptors and it colonizes an organ with extreme chemical gradients. This proposal
builds on our novel insights into the ligands and sensing mechanisms of H. pylori chemoreceptors. In this
proposal, we will use structural, biophysical, and biochemical approaches to understand the precise
mechanisms by which H. pylori chemoreceptors sense three key chemicals that define three important axes in
the stomach environment: urea (secreted from the gastric epithelium, defining the epithelial to luminal axis), the
bacterial-produced quorum sensing molecule autoinducer-2 (defining regions of high bacterial density in the
gastric glands versus the overlying mucosa), and acid (produced by the parietal cells in the anterior corpus
region, defining the corpus to antrum, as well as the epithelial to luminal axis in the corpus). We have
engineered mutant H. pylori that are specifically defective in sensing one of these three chemicals and we
have developed highly sensitive assays for quantifying H. pylori chemotactic responses. We will use these
existing mutants, and others that we engineer based on our new insights into the chemosensing mechanisms,
to understand how H. pylori cells organize themselves in response to chemical signals on cultured epithelial
monolayers and during infection of the mouse stomach. Knowledge gained from these studies will lead to new
strategies for preventing and treating H. pylori infections by altering the bacteria's distribution in the stomach.
More generally, these studies will provide novel insights into how bacterial pathogens perceive and navigate
the host environment, knowledge which will be crucial for designing the next generation of antibiotics that
specifically target within-host properties of bacterial invaders.
项目概要
幽门螺杆菌是一种人类胃部病原体,它寄生在世界上一半的人口中,并导致广泛的
一系列疾病,包括胃炎、溃疡和癌症。细菌在胃内的分布是
与疾病结果相关,但决定这种分布的因素尚不清楚。我们假设
趋化性,即细菌根据化学梯度感知和定向其运动的能力
它们的环境是幽门螺杆菌在胃中分布的关键决定因素。幽门螺杆菌非常适合
测试细菌趋化性在组织分布中的作用,因为它具有简单的趋化系统
只有三个核心化学感受器,并且它以极端的化学梯度定植于一个器官。这个提议
建立在我们对幽门螺杆菌化学感受器的配体和传感机制的新见解的基础上。在这个
建议,我们将使用结构、生物物理和生化方法来理解精确的
幽门螺杆菌化学感受器感知三种关键化学物质的机制,这些化学物质定义了三个重要轴
胃环境:尿素(从胃上皮分泌,定义上皮到腔轴),
细菌产生的群体感应分子 autoinducer-2(定义细菌密度高的区域)
胃腺与上层粘膜)和酸(由前体壁细胞产生)
区域,定义了主体到窦,以及主体中的上皮到管腔轴)。我们有
工程改造的幽门螺杆菌突变体在感知这三种化学物质之一方面存在特殊缺陷,我们
已经开发出用于量化幽门螺杆菌趋化反应的高灵敏度测定法。我们将使用这些
现有的突变体,以及我们根据对化学传感机制的新见解设计的其他突变体,
了解幽门螺杆菌细胞如何组织自身以响应培养上皮细胞上的化学信号
单层细胞和小鼠胃感染期间。从这些研究中获得的知识将带来新的
通过改变细菌在胃中的分布来预防和治疗幽门螺杆菌感染的策略。
更一般地说,这些研究将为细菌病原体如何感知和导航提供新的见解。
宿主环境和知识对于设计下一代抗生素至关重要
专门针对细菌入侵者的宿主内特性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen J Guillemin其他文献
Karen J Guillemin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen J Guillemin', 18)}}的其他基金
Engineering microbiota to optimize population-level health
工程微生物群以优化人群健康
- 批准号:
10227108 - 财政年份:2018
- 资助金额:
$ 32.24万 - 项目类别:
Engineering microbiota to optimize population-level health
工程微生物群以优化人群健康
- 批准号:
10468041 - 财政年份:2018
- 资助金额:
$ 32.24万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
8997473 - 财政年份:2014
- 资助金额:
$ 32.24万 - 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
- 批准号:
9318540 - 财政年份:2014
- 资助金额:
$ 32.24万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
8629573 - 财政年份:2014
- 资助金额:
$ 32.24万 - 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
- 批准号:
9118193 - 财政年份:2014
- 资助金额:
$ 32.24万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
9207745 - 财政年份:2014
- 资助金额:
$ 32.24万 - 项目类别:
相似国自然基金
HJURP调控PRDX1增加雄激素受体蛋白稳定性导致前列腺癌细胞对恩扎卢胺耐药的机制
- 批准号:82373188
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
USP46通过去泛素化修饰RAP80促进同源重组修复的分子机制及其在三阴乳腺癌中的功能研究
- 批准号:82373150
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
FERMT2/DDX3X信号轴促进胰腺癌发生发展的作用及机制研究
- 批准号:82372605
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
缺氧诱导USP10线粒体内膜转位促进胰腺癌糖酵解和转移的机制研究
- 批准号:82372948
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
抑制MRPS21协同Bcl-xL抑制剂诱导前列腺癌细胞合成致死的分子机制研究
- 批准号:82303033
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of drug conjugates of R-spondin peptibodies for the treatment of colorectal cancer
开发用于治疗结直肠癌的 R-spondin 肽体药物缀合物
- 批准号:
10696733 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Molecular engineering and systematic evaluation of bispecific aptamers to develop potent and efficacious therapies for the immunomodulation of Non-Small Cell Lung Cancer
双特异性适体的分子工程和系统评估,以开发有效的非小细胞肺癌免疫调节疗法
- 批准号:
10751309 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Ligand-Directed KRAS G12V Mutant-Specific Therapeutics
配体导向的 KRAS G12V 突变特异性治疗
- 批准号:
10757070 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Unmet needs for specific subsets of EGFR mutated lung cancer
EGFR 突变肺癌特定亚型的需求未得到满足
- 批准号:
10441928 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
ST6GalNAc-I/MUC5AC promoting angiogenesis in lung adenocarcinoma
ST6GalNAc-I/MUC5AC促进肺腺癌血管生成
- 批准号:
10513140 - 财政年份:2022
- 资助金额:
$ 32.24万 - 项目类别: